CAS 1883602-21-8
:3-[[[5-Cyano-1,6-dihydro-6-oxo-4-(2-thienyl)-2-pyrimidinyl]thio]methyl]benzeneacetic acid
Description:
3-[[[5-Cyano-1,6-dihydro-6-oxo-4-(2-thienyl)-2-pyrimidinyl]thio]methyl]benzeneacetic acid is a chemical compound characterized by its complex structure, which includes a benzeneacetic acid moiety linked to a thioether and a pyrimidine derivative. The presence of a cyano group and a thienyl substituent contributes to its potential biological activity, making it of interest in pharmaceutical research. The compound likely exhibits properties such as solubility in organic solvents and moderate stability under standard conditions, although specific solubility and stability data would depend on the environment and formulation. Its molecular structure suggests potential interactions with biological targets, which may be explored in drug development. The compound's unique functional groups may also influence its reactivity and interactions with other chemical species. Overall, this substance represents a class of compounds that could have applications in medicinal chemistry, particularly in the development of novel therapeutic agents.
Formula:C18H13N3O3S2
InChI:InChI=1S/C18H13N3O3S2/c19-9-13-16(14-5-2-6-25-14)20-18(21-17(13)24)26-10-12-4-1-3-11(7-12)8-15(22)23/h1-7H,8,10H2,(H,22,23)(H,20,21,24)
InChI key:InChIKey=RJQYGCGMQYVVIB-UHFFFAOYSA-N
SMILES:C(#N)C1=C(NC(SCC2=CC(CC(O)=O)=CC=C2)=NC1=O)C3=CC=CS3
Synonyms:- 3-[[[5-Cyano-1,6-dihydro-6-oxo-4-(2-thienyl)-2-pyrimidinyl]thio]methyl]benzeneacetic acid
- Benzeneacetic acid, 3-[[[5-cyano-1,6-dihydro-6-oxo-4-(2-thienyl)-2-pyrimidinyl]thio]methyl]-
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
TES-1025
CAS:TES-1025 is an effective and selective inhibitor of human α-amino-β-carboxymuconate-ε-semialdehyde decarboxylase (IC50: 13 nM).Formula:C18H13N3O3S2Purity:98.8%Color and Shape:SolidMolecular weight:383.44TES-1025
CAS:<p>TES-1025 is a small molecule that was discovered through the use of a high-throughput screening process. It is a Sirtuin inhibitor that has been shown to have cancer prevention and treatment properties in vitro and in vivo. TES-1025 binds to the molecular target, SirT1, which inhibits the enzyme's ability to regulate metabolism and cell growth. TES-1025 has also been shown to be effective against cisplatin-resistant cells by boosting biosynthesis. This drug also reduces serum alanine levels in mice with metabolic disorders and tissue damage due to sensorineural hearing loss.</p>Formula:C18H13N3O3S2Purity:Min. 95%Molecular weight:383.44 g/mol



